Literature DB >> 7946110

Seroincidence of HIV-1 infection in African women of reproductive age: a prospective cohort study in Kigali, Rwanda, 1988-1992.

V Leroy1, P Van de Perre, P Lepage, J Saba, F Nsengumuremyi, A Simonon, E Karita, P Msellati, R Salamon, F Dabis.   

Abstract

OBJECTIVE: To estimate the seroincidence of HIV-1 infection among women of reproductive age in Kigali, Rwanda.
DESIGN: Fixed prospective cohort followed for 36 months between November 1988 and June 1992, as part of an ongoing study of mother-to-child transmission of HIV-1.
SETTING: Centre Hospitalier, Kigali, Rwanda.
SUBJECTS: A total of 216 HIV-seronegative women were enrolled at delivery between November 1988 and June 1989.
METHODS: A blood sample was obtained at delivery to test for HIV antibodies (by enzyme-linked immunosorbent assay and Western blot). Serum was tested every 3 months during follow-up. Incidence density rates of HIV seroconversion were estimated.
RESULTS: The follow-up rate after 3 years was 89%, assessed by the maximum person-years method. The seroincidence density rate was 3.5 per 100 women-years (95% confidence interval, 1.9-5.0). It decreased linearly from 7.6 during the first 6-months postpartum to 2.5 per 100 women-years during the last 6 months of the third year of follow-up. Maternal age did not affect HIV incidence rates. We examined the role of the cohort, counselling, and the first 6-month postpartum effects on this estimate.
CONCLUSION: This fixed cohort provided an overall estimation of the HIV infection incidence rate and its dynamics. These figures could be used for programming future HIV preventive vaccine efficacy trials in Rwanda.

Entities:  

Keywords:  Africa; Africa South Of The Sahara; Biology; Cohort Analysis--women; Developing Countries; Diseases; Eastern Africa; Examinations And Diagnoses; French Speaking Africa; Hiv Infections--women; Hiv Serodiagnosis; Immunity; Laboratory Examinations And Diagnoses; Physiology; Postpartum Women; Prospective Studies; Puerperium; Reproduction; Research Report; Rwanda; Seroconversion; Studies; Viral Diseases

Mesh:

Year:  1994        PMID: 7946110     DOI: 10.1097/00002030-199407000-00017

Source DB:  PubMed          Journal:  AIDS        ISSN: 0269-9370            Impact factor:   4.177


  23 in total

1.  Effect of HIV infection on body composition and fat distribution in Rwandan women.

Authors:  Eugene Mutimura; Kathryn Anastos; Mardge Cohen; Agnes Binagwaho; Donald P Kotler
Journal:  J Int Assoc Physicians AIDS Care (Chic)       Date:  2010 May-Jun

2.  Comparison of Follicular and Luteal Phase Mucosal Markers of HIV Susceptibility in Healthy Women.

Authors:  Andrea Ries Thurman; Neelima Chandra; Nazita Yousefieh; Irina Zalenskaya; Thomas Kimble; Susana Asin; Christiane Rollenhagen; Sharon M Anderson; Betsy Herold; Pedro M M Mesquita; Nicola Richardson-Harman; Tina Cunningham; Jill L Schwartz; Gustavo F Doncel
Journal:  AIDS Res Hum Retroviruses       Date:  2016-02-10       Impact factor: 2.205

3.  The contribution of maternal HIV seroconversion during late pregnancy and breastfeeding to mother-to-child transmission of HIV.

Authors:  Leigh F Johnson; Kathryn Stinson; Marie-Louise Newell; Ruth M Bland; Harry Moultrie; Mary-Ann Davies; Thomas M Rehle; Rob E Dorrington; Gayle G Sherman
Journal:  J Acquir Immune Defic Syndr       Date:  2012-04-01       Impact factor: 3.731

Review 4.  Perinatal transmission of HIV and diagnosis of HIV infection in infants: a review.

Authors:  C B Nourse; K M Butler
Journal:  Ir J Med Sci       Date:  1998 Jan-Mar       Impact factor: 1.568

5.  A Risk Assessment Tool for Identifying Pregnant and Postpartum Women Who May Benefit From Preexposure Prophylaxis.

Authors:  Jillian Pintye; Alison L Drake; John Kinuthia; Jennifer A Unger; Daniel Matemo; Renee A Heffron; Ruanne V Barnabas; Pamela Kohler; R Scott McClelland; Grace John-Stewart
Journal:  Clin Infect Dis       Date:  2017-03-15       Impact factor: 9.079

6.  Increased risk of HIV-1 transmission in pregnancy: a prospective study among African HIV-1-serodiscordant couples.

Authors:  Nelly R Mugo; Renee Heffron; Deborah Donnell; Anna Wald; Edwin O Were; Helen Rees; Connie Celum; James N Kiarie; Craig R Cohen; Kayitesi Kayintekore; Jared M Baeten
Journal:  AIDS       Date:  2011-09-24       Impact factor: 4.177

7.  Should screening of genital infections be part of antenatal care in areas of high HIV prevalence? A prospective cohort study from Kigali, Rwanda, 1992-1993. The Pregnancy and HIV (EGE) Group.

Authors:  V Leroy; A De Clercq; J Ladner; J Bogaerts; P Van de Perre; F Dabis
Journal:  Genitourin Med       Date:  1995-08

8.  HIV-1 incidence and HIV-1 associated mortality in a cohort of urban factory workers in Tanzania.

Authors:  M W Borgdorff; L R Barongo; A H Klokke; J N Newell; K P Senkoro; J P Velema; R M Gabone
Journal:  Genitourin Med       Date:  1995-08

9.  Incidence of human immunodeficiency virus antibody in a prenatal population at a community hospital.

Authors:  T S Alexander; J Lee; B Yen-Lieberman
Journal:  Clin Diagn Lab Immunol       Date:  1999-01

10.  Depot medroxyprogesterone acetate increases immune cell numbers and activation markers in human vaginal mucosal tissues.

Authors:  Neelima Chandra; Andrea Ries Thurman; Sharon Anderson; Tina Duong Cunningham; Nazita Yousefieh; Christine Mauck; Gustavo F Doncel
Journal:  AIDS Res Hum Retroviruses       Date:  2012-11-28       Impact factor: 2.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.